## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence as presented in the abstract; no figures, tables, methods, or supplementary materials were provided
- **Shared manuscript claim summary** The authors report single-cell RNA sequencing (scRNA-seq) and assay for transposase-accessible chromatin using sequencing (ATAC-seq) on mouse aortas at 4, 26, and 86 weeks of age. They claim integration of transcriptomic and chromatin accessibility data reveals cell-specific transcription factor regulatory networks, altered cell interactions, inflammation, cell type composition changes, dysregulation of transcriptional control, and chromatin accessibility changes during aortic aging. They further claim endothelial cell 1 shows higher senescence-related gene set activity than endothelial cell 2, and that senescence trajectories link endothelial cell 1 and fibroblast senescence to distinct open chromatin states and mRNA expression models.
- **Visible evidence base** Abstract text only; no quantitative results, statistical measures, or methodological details are provided
- **Missing materials affecting confidence** Full manuscript, all figures, tables, methods section, supplementary data, statistical analyses, and any validation experiments

## Reviewer
- **Overall assessment** The abstract presents a potentially interesting systems-level dataset combining scRNA-seq and ATAC-seq to study aortic aging in mice. However, the claims are broad and largely descriptive, and the abstract lacks quantitative evidence, methodological transparency, and validation. The central conclusions about cell-specific regulatory networks and senescence trajectories cannot be evaluated from the supplied material. The work may be of interest to vascular biologists and aging researchers, but the current evidence base is insufficient to establish the stated claims.
- **Who would be interested in the results, and why** Researchers studying vascular aging, cellular senescence, transcriptional and epigenetic regulation in the vasculature, and those applying single-cell multi-omics approaches to tissue aging. The integration of transcriptome and chromatin accessibility at single-cell resolution could provide a resource for hypothesis generation in these fields.
- **Major strengths** The study addresses a relevant and understudied topic, namely cell-type-specific mechanisms of aortic aging. The use of two complementary single-cell modalities (scRNA-seq and ATAC-seq) across three age points is a reasonable design for capturing dynamic changes. The focus on endothelial cell heterogeneity and senescence trajectories is a potentially valuable contribution.
- **Major Concerns**  
  - **Concern ID** R1-M1  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Evidence sufficiency  
  - **Claim pointer** The authors claim that integration of transcriptome and chromatin accessibility data identified cell-specific TF regulatory networks and open chromatin states during aortic aging.  
  - **Evidence pointer** Abstract; location not provided  
  - **Concern** No quantitative results, statistical tests, or effect sizes are reported to support the identification of specific regulatory networks or changes in open chromatin states. The abstract does not state which TFs were identified, how networks were constructed, or how significance was assessed.  
  - **Why it matters** Without quantitative support, the claim of identified regulatory networks is unverifiable and could be based on arbitrary thresholds or non-robust analyses.  
  - **Resolution test** Provide specific TF networks with statistical significance, effect sizes, and validation (e.g., motif enrichment, perturbation experiments) in the full manuscript.

  - **Concern ID** R1-M2  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Evidence sufficiency  
  - **Claim pointer** The authors claim that aortic aging affects cell interactions, inflammation, cell type composition, dysregulation of transcriptional control, and chromatin accessibility.  
  - **Evidence pointer** Abstract; location not provided  
  - **Concern** These are five distinct and broad claims, but the abstract provides no data on any of them. No metrics for cell-cell interaction changes, inflammatory gene expression, cell type proportion shifts, or chromatin accessibility differences are given.  
  - **Why it matters** The claims are central to the paper's conclusion of a system-wide model, but without quantitative evidence they remain assertions.  
  - **Resolution test** Report specific changes with statistical significance for each of the five areas, including direction and magnitude of effects.

  - **Concern ID** R1-M3  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Evidence sufficiency  
  - **Claim pointer** The authors claim that endothelial cell 1 has higher gene set activity related to cellular senescence and aging than endothelial cell 2, and that senescence trajectories show distinct TF open chromatin states and mRNA expression models.  
  - **Evidence pointer** Abstract; location not provided  
  - **Concern** No details are provided on how endothelial cell subtypes were defined, how gene set activity was scored, what senescence trajectory analysis was used, or which TFs and genes were involved. The claim of distinct states is not supported by any data.  
  - **Why it matters** These are the most specific and novel claims, but they are entirely unquantified and unvalidated. Without methodological detail and statistical support, the conclusions are not credible.  
  - **Resolution test** Provide subtype definitions, gene set scoring methods, trajectory inference details, and statistical comparisons with effect sizes and confidence intervals.

- **Minor Comments**  
  - **Concern ID** R1-m1  
  - **Severity** Minor  
  - **Axis** Clarity  
  - **Affected element** Title  
  - **Evidence pointer** Title  
  - **Issue** The title is overly long and redundant, repeating "Sequencing" twice.  
  - **Required correction** Shorten and rephrase for clarity, e.g., "Single-Cell RNA and ATAC Sequencing Reveal Cellular and Molecular Dynamics of Aortic Aging in Mice."

  - **Concern ID** R1-m2  
  - **Severity** Minor  
  - **Axis** Reproducibility  
  - **Affected element** Methods description  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** The abstract does not mention biological replicates, data processing pipelines, or quality control metrics for scRNA-seq and ATAC-seq.  
  - **Required correction** Include replicate numbers and key QC parameters in the abstract or methods summary.

  - **Concern ID** R1-m3  
  - **Severity** Minor  
  - **Axis** Interpretation  
  - **Affected element** Conclusion  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** The conclusion states a "system-wide model" but the abstract only describes descriptive observations without a model or predictive framework.  
  - **Required correction** Clarify what constitutes the model, or temper the conclusion to reflect descriptive findings.

- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3. The absence of quantitative results, statistical validation, and methodological detail means the core claims are not currently supported.

- **Assessment against Nature-style criteria**  
  - **Originality** The combination of scRNA-seq and ATAC-seq across three age points in aortic tissue is not entirely novel but is a reasonable application. The focus on endothelial cell heterogeneity and senescence trajectories adds some originality.  
  - **Scientific importance** Vascular aging is a relevant topic, but the abstract does not demonstrate that the findings substantially advance mechanistic understanding beyond descriptive cataloging.  
  - **Interdisciplinary readership** The work may appeal to vascular biologists, aging researchers, and computational biologists, but the abstract is too vague to attract broad interdisciplinary interest.  
  - **Technical soundness** Cannot be assessed from the abstract. No details on data quality, analysis methods, or validation are provided.  
  - **Readability for nonspecialists** The abstract is readable but uses jargon without explanation, and the lack of concrete results reduces accessibility.

- **Recommendation posture** Currently not established from the provided evidence. The abstract presents a plausible study design but lacks the quantitative and methodological support needed to evaluate the claims. A full manuscript with detailed results, statistics, and validation would be required to assess whether the conclusions are justified.

## Risk / unsupported claims
- The claim of identified cell-specific TF regulatory networks is unsupported without quantitative data.
- The claim that aortic aging affects five distinct biological processes (cell interactions, inflammation, cell type composition, transcriptional control, chromatin accessibility) is unsupported without specific metrics.
- The claim of distinct senescence trajectories for endothelial cell 1 and fibroblasts is unsupported without trajectory analysis details and statistical evidence.
- The conclusion of a "system-wide model" is not supported by the descriptive observations described in the abstract.